Bacterial Infections | I & C | Invest in Quality. Contribute to Society.


ProductStrengthPack Size
Amikacin Solution for Injection (Amiwok)500mg/2ml1 vial / box
Cefepime for Injection USP1000mg1 vial / box
Ciprofloxacin Solution for Infusion200mg/100ml10 bags / box
Clindamycin Capsules150mg100 capsules / box
Daptomycin Powder for Solution for Injection or Infusion500mg1 vial / box
Imipenem/Cilastatin Powder for Solution for Infusion (Prepenem)500mg/500mg10 vials / box
Levofloxacin Solution for Infusion500mg/100ml1 vial / box
Levofloxacin Tablets250mg10 tablets / box
50 tablets / bottle
100 tablets / box
Linezolid Tablets (Lizedia)600mg10 tablets / box
Meropenem Powder for Solution for Injection or Infusion500mg10 vials / box
Meropenem Powder for Solution for Injection or Infusion1g10 vials / box
Moxifloxacin Tablets (Rivomoxi)400mg10 tablets / box
* The above product list shows our products which are approved by Hong Kong Department of Health only. It does not mean that all products are already placed in the market. For any product or business enquiries please contact us at or (852) 2891 0581 for further details.

Bacterial Infections

Although a majority of bacteria are harmless, some may cause bacterial infections. Bacterial infections can be treated with antibiotics. However, antimicrobial spectrum among different antibiotics varies. Before the responsible pathogen is identified, broad-spectrum antibiotics are often prescribed as an empirical therapy for severe infections.

Carbapenems (e.g. Imipenem/Cilastatin, Meropenem) are effective against Gram-positive, Gram-negative and anaerobic bacteria. They are the treatment of choice against ESBL-producing bacteria, which are resistant to most penicillins and cephalosporins. For MRSA infections, other antibiotics should be considered due to carbapenem resistance. Imipenem/Cilastatin is not recommended in bacterial meningitis due to potential risk of seizures.

Fluoroquinolones (e.g. Ciprofloxacin, Levofloxacin, Moxifloxacin) are effective against Gram-positive and Gram-negative bacteria. They are commonly used in patients with penicillin allergy. However, they are associated with an increased risk of tendonitis and tendon rupture. They are also contraindicated in pregnancy. Moxifloxacin is a fourth-generation fluoroquinolone. It is more potent and less likely to develop bacterial resistance than other fluoroquinolones.

Aminoglycosides (e.g. Gentamicin, Amikacin) are effective against Gram-negative bacteria. They are the treatment of choice against against Pseudomonas aeruginosa, which are resistant to a variety of antibiotics. However, they are potentially nephrotoxic and ototoxic and patients must be carefully monitored. Amikacin is effective against bacteria that are resistant to gentamicin and other aminoglycosides.